(RNS) — A lawsuit filed by the pharmaceutical giant alleges that Bishop Jerry Maynard Sr. and Elder Readus C. Smith III, a national COGIC leader, worked with wholesalers to submit fraudulent drug reimbursement claims.

Lilly’s currently approved injection, Zepbound, and Novo Nordisk’s Wegovy have shown weight loss of roughly 15% to 20% in different trials, according to Reuters, while Lilly’s oral ​obesity pill, Foundayo, has delivered about 11% weight loss.

Eli Lilly claims in a civil lawsuit that it's the victim of a $200 million plus drug rebate fraud tied to Pentecostal church bishops and businesses.

The pharmaceutical company claims four members of the Church of God in Christ fraudulently resold a discounted diabetes drug.

The US Supreme Court said Monday it won’t review Eli Lilly and Co.'s challenge to a $193 million Medicaid drug fraud judgment in a whistleblower’s False Claims Act suit.

Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.

Lilly's retatrutide may have the best weight loss efficacy so far, but analysts are concerned around its tolerability compared with tirzepatide.

Eli Lilly and Company (NYSE: LLY) today announced the details of presentations from across its oncology portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 - June 2 in Chicago,